As a disease with complex heterogeneity, TNBC not only lacks the expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 at hormone level, but also shows more diversity at molecular genetic level compared with other subtypes of breast cancer (Kalimutho et al., 2015). The gene discussed is ESR1; the disease is breast carcinoma.